Cargando…

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling

BACKGROUND: Accumulating evidence suggests that M2-polarized tumor-associated macrophages (TAMs) play an important role in cancer progression and metastasis, making M2 polarization of TAMs an ever more appealing target for therapeutic intervention. Astragaloside IV (AS-IV), a saponin component isola...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fei, Cui, Wen-Qiang, Wei, Ying, Cui, Jie, Qiu, Jian, Hu, Ling-Li, Gong, Wei-Yi, Dong, Jing-Cheng, Liu, Bao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116548/
https://www.ncbi.nlm.nih.gov/pubmed/30157903
http://dx.doi.org/10.1186/s13046-018-0878-0
_version_ 1783351625928146944
author Xu, Fei
Cui, Wen-Qiang
Wei, Ying
Cui, Jie
Qiu, Jian
Hu, Ling-Li
Gong, Wei-Yi
Dong, Jing-Cheng
Liu, Bao-Jun
author_facet Xu, Fei
Cui, Wen-Qiang
Wei, Ying
Cui, Jie
Qiu, Jian
Hu, Ling-Li
Gong, Wei-Yi
Dong, Jing-Cheng
Liu, Bao-Jun
author_sort Xu, Fei
collection PubMed
description BACKGROUND: Accumulating evidence suggests that M2-polarized tumor-associated macrophages (TAMs) play an important role in cancer progression and metastasis, making M2 polarization of TAMs an ever more appealing target for therapeutic intervention. Astragaloside IV (AS-IV), a saponin component isolated from Astragali radix, has been reported to inhibit the invasion and metastasis of lung cancer, but its effects on TAMs during lung cancer progression have not been investigated. METHODS: Human THP-1 monocytes were induced to differentiate into M2 macrophages through treatments with IL-4, IL-13, and phorbol myristate acetate (PMA). We used the lung cancer cell lines A549 and H1299 cultured in conditioned medium from M2 macrophages (M2-CM) to investigate the effects of AS-IV on tumor growth, invasion, migration, and angiogenesis of lung cancer cells. Macrophage subset distribution, M1 and M2 macrophage-associated markers, and mRNA expression were analyzed by flow cytometry and quantitative PCR. The activation of adenosine monophosphate-activated protein kinase (AMPK) signaling pathways that mediate M2-CM–promoted tumor migration was detected using western blotting. RESULTS: Here we found that AS-IV significantly inhibited IL-13 and IL-4–induced M2 polarization of macrophages, as illustrated by reduced expression of CD206 and M2-associated genes, and that AS-IV suppressed the M2-CM–induced invasion, migration, and angiogenesis of A549 and H1299 cells. In vivo experiments demonstrated that AS-IV greatly inhibited tumor growth and reduced the number of metastases of Lewis lung cancer. The percentage of M2 macrophages was decreased in tumor tissue after AS-IV treatment. Furthermore, AS-IV inhibited AMPKα activation in M2 macrophages, and silencing of AMPKα partially abrogated the inhibitory effect of AS-IV. CONCLUSIONS: AS-IV reduced the growth, invasion, migration, and angiogenesis of lung cancer by blocking the M2 polarization of macrophages partially through the AMPK signaling pathway, which appears to play an important role in AS-IV’s ability to inhibit the metastasis of lung cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0878-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6116548
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61165482018-10-02 Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling Xu, Fei Cui, Wen-Qiang Wei, Ying Cui, Jie Qiu, Jian Hu, Ling-Li Gong, Wei-Yi Dong, Jing-Cheng Liu, Bao-Jun J Exp Clin Cancer Res Research BACKGROUND: Accumulating evidence suggests that M2-polarized tumor-associated macrophages (TAMs) play an important role in cancer progression and metastasis, making M2 polarization of TAMs an ever more appealing target for therapeutic intervention. Astragaloside IV (AS-IV), a saponin component isolated from Astragali radix, has been reported to inhibit the invasion and metastasis of lung cancer, but its effects on TAMs during lung cancer progression have not been investigated. METHODS: Human THP-1 monocytes were induced to differentiate into M2 macrophages through treatments with IL-4, IL-13, and phorbol myristate acetate (PMA). We used the lung cancer cell lines A549 and H1299 cultured in conditioned medium from M2 macrophages (M2-CM) to investigate the effects of AS-IV on tumor growth, invasion, migration, and angiogenesis of lung cancer cells. Macrophage subset distribution, M1 and M2 macrophage-associated markers, and mRNA expression were analyzed by flow cytometry and quantitative PCR. The activation of adenosine monophosphate-activated protein kinase (AMPK) signaling pathways that mediate M2-CM–promoted tumor migration was detected using western blotting. RESULTS: Here we found that AS-IV significantly inhibited IL-13 and IL-4–induced M2 polarization of macrophages, as illustrated by reduced expression of CD206 and M2-associated genes, and that AS-IV suppressed the M2-CM–induced invasion, migration, and angiogenesis of A549 and H1299 cells. In vivo experiments demonstrated that AS-IV greatly inhibited tumor growth and reduced the number of metastases of Lewis lung cancer. The percentage of M2 macrophages was decreased in tumor tissue after AS-IV treatment. Furthermore, AS-IV inhibited AMPKα activation in M2 macrophages, and silencing of AMPKα partially abrogated the inhibitory effect of AS-IV. CONCLUSIONS: AS-IV reduced the growth, invasion, migration, and angiogenesis of lung cancer by blocking the M2 polarization of macrophages partially through the AMPK signaling pathway, which appears to play an important role in AS-IV’s ability to inhibit the metastasis of lung cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0878-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-29 /pmc/articles/PMC6116548/ /pubmed/30157903 http://dx.doi.org/10.1186/s13046-018-0878-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Xu, Fei
Cui, Wen-Qiang
Wei, Ying
Cui, Jie
Qiu, Jian
Hu, Ling-Li
Gong, Wei-Yi
Dong, Jing-Cheng
Liu, Bao-Jun
Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
title Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
title_full Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
title_fullStr Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
title_full_unstemmed Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
title_short Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
title_sort astragaloside iv inhibits lung cancer progression and metastasis by modulating macrophage polarization through ampk signaling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116548/
https://www.ncbi.nlm.nih.gov/pubmed/30157903
http://dx.doi.org/10.1186/s13046-018-0878-0
work_keys_str_mv AT xufei astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT cuiwenqiang astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT weiying astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT cuijie astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT qiujian astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT hulingli astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT gongweiyi astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT dongjingcheng astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling
AT liubaojun astragalosideivinhibitslungcancerprogressionandmetastasisbymodulatingmacrophagepolarizationthroughampksignaling